ATG12 — Autophagy Related 12

ATG12 — Autophagy Related 12

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">atg12</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Size</td>
</tr>
<tr>
<td class="label">ATG12</td>
<td>140 aa</td>
</tr>
<tr>
<td class="label">ATG5</td>
<td>278 aa</td>
</tr>
<tr>
<td class="label">LC3/MAP1LC3</td>
<td>125 aa</td>
</tr>
<tr>
<td class="label">ATG16L1</td>
<td>661 aa</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">ATG12 overexpression</td>
<td>AAV gene therapy</td>
</tr>
<tr>
<td class="label">Autophagy inducers</td>
<td>Rapamycin, trehalose</td>
</tr>
<tr>
<td class="label">TFEB activators</td>
<td>Small molecules</td>
</tr>
<tr>
<td class="label">Combination therapy</td>
<td>Autophagy + neuroprotection</td>
</tr>
</table>

ATG12 — Autophagy Related 12

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">atg12</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Size</td>
</tr>
<tr>
<td class="label">ATG12</td>
<td>140 aa</td>
</tr>
<tr>
<td class="label">ATG5</td>
<td>278 aa</td>
</tr>
<tr>
<td class="label">LC3/MAP1LC3</td>
<td>125 aa</td>
</tr>
<tr>
<td class="label">ATG16L1</td>
<td>661 aa</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">ATG12 overexpression</td>
<td>AAV gene therapy</td>
</tr>
<tr>
<td class="label">Autophagy inducers</td>
<td>Rapamycin, trehalose</td>
</tr>
<tr>
<td class="label">TFEB activators</td>
<td>Small molecules</td>
</tr>
<tr>
<td class="label">Combination therapy</td>
<td>Autophagy + neuroprotection</td>
</tr>
</table>

:: infobox .infobox-gene Symbol: ATG12 Full Name: [Autophagy](/entities/autophagy) Related 12 Chromosomal Location: 5q21.2 NCBI Gene ID: [9459](https://www.ncbi.nlm.nih.gov/gene/9459) [@kirisako2000] OMIM: [609548](https://omim.org/entry/609548) [@ichimura2000] Ensembl ID: [ENSG00000181458](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000181458) [@shintani1999] UniProt: [O95166](https://www.uniprot.org/uniprot/O95166) [@hanada2007] Proteins: [ATG12 Protein](/proteins/atg12) [@kabeya2000] Associated Diseases: [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [Huntington's Disease](/diseases/huntingtons), [ALS](/diseases/amyotrophic-lateral-sclerosis) [@mizushima2003]
:: [@johansen2011]

ATG12 — Autophagy Related 12

Pathway Diagram

Introduction

Atg12 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@hailey2010]

Overview

ATG12 (Autophagy Related 12) is a ubiquitin-like protein that plays an essential role in the autophagy pathway, the cellular process responsible for degrading and recycling cytoplasmic components, including misfolded proteins and damaged organelles [1]. Located on chromosome 5q21.2, ATG12 encodes a 140-amino acid protein that undergoes covalent conjugation with ATG5 to form the ATG12-ATG5 conjugate, a critical component of the autophagosome formation machinery [2]. This gene is essential for cellular homeostasis, and its dysfunction is strongly implicated in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease) (AD), [Parkinson's disease](/diseases/parkinsons-disease-disease) (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) [3][4]. [@settembre2011]

Molecular Function

Ubiquitin-Like Conjugation System

ATG12 is part of the ubiquitin-like protein family involved in autophagy: [@egan2011]

ATG12-ATG5 Complex Functions

The ATG12-ATG5 conjugate serves critical functions: [@liu2020]

• LC3 lipidation: Facilitates conversion of LC3-I to LC3-II (phosphatidylethanolamine-conjugated form) [9].
• Phagophore expansion: Promotes expansion and closure of the isolation membrane to form autophagosomes [10].
• Selective autophagy: Works with autophagy receptors (p62, NBR1, OPTN) for selective cargo recognition [11].
• Non-canonical functions: ATG12-ATG5 conjugate can function independently in [apoptosis](/entities/apoptosis) regulation and immune signaling [12].

Comparison with Other ATG Proteins

Expression and Regulation

Tissue Expression

ATG12 is ubiquitously expressed with high levels in: [@narendra2008]

• Brain: Cerebral [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus) (particularly CA3 pyramidal neurons), cerebellum Purkinje cells
• Liver: Hepatocytes for basal autophagy
• Heart: Cardiomyocytes for protein quality control
• Skeletal muscle: Muscle fibers

Cellular Localization

• Cytoplasmic: Primarily cytosolic distribution
• Autophagosomal membrane: Transient association during autophagosome formation
• Mitochondrial: Under certain stress conditions [13]

Regulation

ATG12 expression is regulated by: [@winslow2010]

• Transcriptional: [TFEB](/entities/tfeb) and TFE3 (transcription factors) activate ATG12 during starvation [14].
• Post-translational: Phosphorylation by ULK1 complex modulates ATG12-ATG5 complex formation [15].
• Feedback loops: Autophagy inhibitors can regulate ATG12 expression in disease states [16].

Role in Neurodegenerative Diseases

Alzheimer's Disease

In Alzheimer's disease, ATG12-mediated autophagy is critically impaired [17]: [@fujita2013]

• Autophagy-lysosomal dysfunction: AD brains show accumulation of autophagic vesicles, reflecting impaired ATG12-dependent autophagosome formation or maturation [18].
• [Amyloid-beta](/proteins/amyloid-beta) toxicity: Aβ oligomers disrupt ATG12-ATG5 complex function, reducing clearance of Aβ aggregates [19].
• [Tau](/proteins/tau) pathology: Impaired autophagy contributes to accumulation of hyperphosphorylated tau [20].
• Neuronal survival: ATG12 deficiency in [neurons](/entities/neurons) exacerbates Aβ-induced cell death [21].

Parkinson's Disease

ATG12 is crucial for PD-relevant processes [22]: [@martinezvicente2010]

• Mitophagy: ATG12-ATG5 complex is required for PINK1/Parkin-mediated mitophagy of damaged mitochondria [23].
• [Alpha-synuclein](/proteins/alpha-synuclein) clearance: ATG12-dependent autophagy clears alpha-synuclein aggregates [24].
• Dopaminergic neuron vulnerability: ATG12 deficiency accelerates loss of dopaminergic neurons in substantia nigra [25].

Huntington's Disease

Mutant [huntingtin protein](/proteins/huntingtin) impairs ATG12 function [26]: [@rui2015]

• Aggregate clearance: Reduced ATG12-ATG5 activity impairs clearance of mutant huntingtin aggregates [27].
• Cargo recognition: Disrupted interaction with autophagy receptors reduces selective autophagy [28].
• Therapeutic target: Enhancing ATG12-mediated autophagy reduces mutant huntingtin toxicity [29].

Amyotrophic Lateral Sclerosis

In ALS, ATG12 dysfunction contributes to disease progression [30]: [@kouroku2007]

• Stress granules: ATG12 required for clearance of stress granules containing mutant SOD1 and [TDP-43](/mechanisms/tdp-43-proteinopathy) [31].
• Motor neuron degeneration: ATG12 deficiency in motor neurons promotes aggregation of misfolded proteins [32].
• RNA toxicity: Impaired autophagy leads to accumulation of toxic RNA-protein aggregates [33].

Therapeutic Implications

Autophagy Enhancement Strategies

• Rapamycin: [mTOR](/mechanisms/mtor-signaling-pathway) inhibition enhances ATG12-mediated autophagy [34].
• Trehalose: TFEB activation increases ATG12 expression [35].
• Carbamazepine: Promotes autophagy through TFEB [36].

• AAV-mediated ATG12 overexpression in neurons [37].
• CRISPR activation of ATG12 promoter [38].

• Autophagy enhancement with抗氧化剂 [39].
• Synergistic effects with mitochondrial protectants [40].

Therapeutic Targeting

Genetics

Common Variants

• ATG12 promoter polymorphisms associated with AD risk in some populations [41].
• rs10514210 variant linked to Parkinson's disease susceptibility [42].

Rare Variants

• Loss-of-function variants cause embryonic lethality in mice [43].
• Missense variants identified in patients with early-onset neurodegeneration [44].

Animal Models

Key models for studying ATG12: [@zhang2017]

• Atg12 knockout mice: Embryonic lethal, severe defects in autophagy [45].
• Conditional neuronal KO: Neurodegeneration and protein aggregate accumulation [46].
• Transgenic ATG12 mice: Enhanced autophagy and neuroprotection [47].

Background

The study of Atg12 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [@zhang2020]

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [@kourtis2019]

Additional evidence sources: [@jia2020] [@sun2019] [@wang2016] [@chen2018] [@kuma2004] [@kim2021] [@komatsu2005a] [@hara2006] [@steele2013]

External Links

• References

Pathway Diagram

The following diagram shows the key molecular relationships involving ATG12 — Autophagy Related 12 discovered through SciDEX knowledge graph analysis: